Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03242343 · ClinicalTrials.gov registry record · NA
VasQ External Support for Arteriovenous Fistula
A NA study, sponsored by Laminate Medical Technologies.
- Completed
- Registry status
- NA
- Development phase
- 144
- Enrollment target
NCT03242343 is a NA study that has completed, run by Laminate Medical Technologies. The registered enrollment target is 144 participants.
The verdict
NCT03242343, a NA study, has completed, sponsored by Laminate Medical Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
Study Summary
This is a prospective clinical study of the VasQ external support for arteriovenous fistulas. The device is designed to improve fistula outcomes by optimizing the geometrical configuration of the fistula, influencing hemodynamics, minimizing turbulence and promote laminar flow. All patients will be implanted with the VasQ device and will be followed up for a duration of 24 months.
Interventions
- DEVICE VasQ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2017-11-29 |
| Est. Completion | 2022-04-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03242343
The ClinicalTrials.gov registry entry for NCT03242343 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Laminate Medical Technologies, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VasQ is the first listed.
NCT03242343 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03242343 about?
NCT03242343 is a clinical study titled "VasQ External Support for Arteriovenous Fistula". This is a prospective clinical study of the VasQ external support for arteriovenous fistulas. The device is designed to improve fistula outcomes by optimizing the geometrical configuration of the fistula, influencing hemodynamics, minimizing turbulence and promote laminar flow. All patients will be...
What is the current status of trial NCT03242343?
This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2017-11-29. Estimated completion is 2022-04-03.
What interventions are being tested in trial NCT03242343?
The interventions under investigation include: VasQ (DEVICE).
Who is sponsoring clinical trial NCT03242343?
This trial is sponsored by Laminate Medical Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.